...
首页> 外文期刊>Kidney and blood pressure research >Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease
【24h】

Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease

机译:加压素对慢性肾脏病,特别是常染色体显性多囊肾的潜在有害作用

获取原文

摘要

The antidiuretic hormone vasopressin is crucial for regulating free water clearance in normal physiology. However, it has also been hypothesized that vasopressin has deleterious effects on the kidney. Vasopressin is elevated in animals and patients with chronic kidney disease. Suppression of vasopressin activity reduces proteinuria, renal hypertrophy, glomerulosclerosis and tubulointerstitial fibrosis in animal models. The potential detrimental influence of vasopressin is probably mediated by its effects on mesangial cell proliferation, renin secretion, renal hemodynamics, and blood pressure. In this review, we discuss the increasing body of evidence pointing towards the contribution of vasopressin to chronic kidney disease progression in general and to autosomal dominant polycystic kidney disease in particular. These data allude to the possibility that interventions directed at lowering vasopressin activity, for example by the administration of vasopressin receptor antagonists or by drinking more water, may be beneficial in chronic kidney disease.
机译:抗利尿激素加压素对于调节正常生理中的游离水清除至关重要。然而,也已经假设加压素对肾脏具有有害作用。动物和患有慢性肾脏疾病的患者体内的加压素水平升高。抑制血管加压素活性可减少动物模型中的蛋白尿,肾肥大,肾小球硬化和肾小管间质纤维化。加压素的潜在有害影响可能是由其对系膜细胞增殖,肾素分泌,肾血流动力学和血压的影响所介导的。在这篇综述中,我们讨论了越来越多的证据表明,加压素通常对慢性肾脏疾病的进展尤其是对常染色体显性多囊性肾脏疾病的贡献。这些数据暗示了针对降低血管加压素活性的干预措施(例如通过施用血管加压素受体拮抗剂或通过喝更多水)可能对慢性肾脏疾病有益的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号